EcoDrugPlus

Protein Kinase C Delta Type-Like

Ensembl ID : ENSOTSG00005027695
Gene Symbol: LOC112217414
3 Cross references
198 Possible Orthologues:

Protein Kinase C Delta Type-Like

Ensembl ID : ENSOTSG00005007622
Gene Symbol: LOC112254618
3 Cross references
198 Possible Orthologues:

Protein Kinase C Epsilon

Ensembl ID : ENSOTSG00005016642
Gene Symbol: PRKCE
1 Cross references
96 Possible Orthologues:

Protein Kinase C Eta Type-Like

Ensembl ID : ENSOTSG00005007650
Gene Symbol: LOC112256767
3 Cross references
218 Possible Orthologues:

Protein Kinase C Iota

Ensembl ID : ENSOTSG00005009959
Gene Symbol: PRKCI
3 Cross references
81 Possible Orthologues:

Protein Kinase C Zeta Type-Like

Ensembl ID : ENSOTSG00005019425
Gene Symbol: LOC112221605
3 Cross references
194 Possible Orthologues:

Protein Kinase C Zeta Type-Like

Ensembl ID : ENSOTSG00005017511
Gene Symbol: LOC112233897
3 Cross references
194 Possible Orthologues:

Protein Kinase C, Alpha, A

Ensembl ID : ENSOTSG00005032461
Gene Symbol: PRKCAA
1 Cross references
207 Possible Orthologues:

Protein Kinase C, Eta, A

Ensembl ID : ENSOTSG00005030428
Gene Symbol: PRKCHA
1 Cross references
218 Possible Orthologues:

Protein Kinase C, Theta

Ensembl ID : ENSOTSG00005010961
Gene Symbol: PRKCQ
1 Cross references
202 Possible Orthologues:

Protein Kinase C, Zeta

Ensembl ID : ENSOTSG00005038810
Gene Symbol: PRKCZ
1 Cross references
194 Possible Orthologues:

Protein Kinase D1

Ensembl ID : ENSOTSG00005009868
Gene Symbol: PRKD1
1 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).